Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Dimaras

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
The British Journal of Ophthalmology|January 8, 2013
Molecular testing prognostic of low risk in epithelioid uveal melanoma in a childHelen Dimaras, Manoj Vijay Parulekar, Grace Kwok, et al.
Nature Reviews. Disease Primers|May 19, 2016
RetinoblastomaHelen Dimaras, Timothy W Corson, David Cobrinik, et al.
Public Health Genomics|July 26, 2014
Developing clinical cancer genetics services in resource-limited countries: the case of retinoblastoma in KenyaLi Qun He, Lucy Njambi, Joseph M Nyamori, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumorShui Yen Soh, Helen Dimaras, Abha Gupta, et al.
Ophthalmology|February 17, 2020
Screening for Pineal Trilateral Retinoblastoma Revisited: A Meta-analysisMarcus C de Jong, Wijnanda A Kors, Annette C Moll, et al.
Acta Ophthalmologica|May 3, 2021
Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysisMarcus C de Jong, Furqan Shaikh, Brenda Gallie, et al.
Pediatric Blood & Cancer|April 13, 2026
Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-CSamuel Sassine, Ofélie Trudeau-Ferrin, Caroline Laverdière, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 21, 2021
Defining Clinical Public HealthBernard Choi, Barry Pakes, Rose Bilotta, et al.
The Lancet. Oncology|March 19, 2013
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studiesDiane E Rushlow, Berber M Mol, Jennifer Y Kennett, et al.
Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
The British Journal of Ophthalmology|January 8, 2013
Molecular testing prognostic of low risk in epithelioid uveal melanoma in a childHelen Dimaras, Manoj Vijay Parulekar, Grace Kwok, et al.
Nature Reviews. Disease Primers|May 19, 2016
RetinoblastomaHelen Dimaras, Timothy W Corson, David Cobrinik, et al.
Public Health Genomics|July 26, 2014
Developing clinical cancer genetics services in resource-limited countries: the case of retinoblastoma in KenyaLi Qun He, Lucy Njambi, Joseph M Nyamori, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 10, 2011
Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumorShui Yen Soh, Helen Dimaras, Abha Gupta, et al.
Ophthalmology|February 17, 2020
Screening for Pineal Trilateral Retinoblastoma Revisited: A Meta-analysisMarcus C de Jong, Wijnanda A Kors, Annette C Moll, et al.
Acta Ophthalmologica|May 3, 2021
Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysisMarcus C de Jong, Furqan Shaikh, Brenda Gallie, et al.
Pediatric Blood & Cancer|April 13, 2026
Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-CSamuel Sassine, Ofélie Trudeau-Ferrin, Caroline Laverdière, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 21, 2021
Defining Clinical Public HealthBernard Choi, Barry Pakes, Rose Bilotta, et al.
The Lancet. Oncology|March 19, 2013
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studiesDiane E Rushlow, Berber M Mol, Jennifer Y Kennett, et al.
Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.
Pageof 11